These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38888192)

  • 41. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
    Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
    Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
    Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
    Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laser Therapy for Genitourinary Syndrome of Menopause.
    Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M
    Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study.
    Pinheiro C; Costa T; Amorim de Jesus R; Campos R; Brim R; Teles A; Vilas Boas A; Lordêlo P
    BMC Womens Health; 2021 Oct; 21(1):379. PubMed ID: 34717608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fractional CO
    Chung YJ; Shim S; Kim S; Cha J; Song JY; Kim MJ; Kim MR
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence.
    Arunkalaivanan A; Kaur H; Onuma O
    Int Urogynecol J; 2017 May; 28(5):681-685. PubMed ID: 28154914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause.
    Barba M; Cola A; De Vicari D; Costa C; Castelli AP; Volontè S; Fruscio R; Frigerio M
    Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fractional CO
    Lang P; Dell JR; Rosen L; Weiss P; Karram M
    Lasers Surg Med; 2017 Dec; 49(10):882-885. PubMed ID: 28881431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women.
    Athanasiou S; Pitsouni E; Antonopoulou S; Zacharakis D; Salvatore S; Falagas ME; Grigoriadis T
    Climacteric; 2016 Oct; 19(5):512-8. PubMed ID: 27558459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Jha S; Wyld L; Krishnaswamy PH
    Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CO
    Athanasiou S; Pitsouni E; Falagas ME; Salvatore S; Grigoriadis T
    Maturitas; 2017 Oct; 104():24-28. PubMed ID: 28923173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microablative Fractional CO
    Salvatore S; Nappi RE; Casiraghi A; Ruffolo AF; Degliuomini R; Parma M; Leone Roberti Maggiore U; Athanasiou S; Candiani M
    Clin Breast Cancer; 2021 Oct; 21(5):e539-e546. PubMed ID: 33745867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaginal epithelial histology before and after fractional CO
    Li FG; Fuchs T; Deans R; McCormack L; Nesbitt-Hawes E; Abbott J; Farnsworth A
    Am J Obstet Gynecol; 2023 Sep; 229(3):278.e1-278.e9. PubMed ID: 37192705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial.
    Gueldini de Moraes AV; Costa-Paiva L; da Costa Machado H; Maciel TF; Mariano FV; Pedro AO
    Menopause; 2024 Apr; 31(4):288-302. PubMed ID: 38412393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CO 2 laser, radiofrequency, and promestriene in the treatment of genitourinary syndrome of menopause in breast cancer survivors: a histomorphometric evaluation of the vulvar vestibule.
    Fernandes MFR; Bianchi-Ferraro AMHM; Sartori MGF; Jármy Di Bella ZIK; Cantarelli GC; Dedonatto C; Vanzin RB; Dardes RCM; Logullo ÂF; Patriarca MT;
    Menopause; 2023 Dec; 30(12):1213-1220. PubMed ID: 37963315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of non-invasive vulvovaginal rejuvenation.
    Photiou L; Lin MJ; Dubin DP; Lenskaya V; Khorasani H
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):716-726. PubMed ID: 31714632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fractional Co
    Alexiades MR
    Lasers Surg Med; 2021 Feb; 53(2):185-198. PubMed ID: 32329093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaginal CO2 laser therapy versus sham for genitourinary syndrome of menopause management: a systematic review and meta-analysis of randomized controlled trials.
    Khamis Y; Abdelhakim AM; Labib K; Islam BA; Nassar SA; Motaal AOA; Saleh DM; Abdou H; Abbas AM; Mojahed EM
    Menopause; 2021 Aug; 28(11):1316-1322. PubMed ID: 34374686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.